In addition, the cisplatin resistance in bladder cancer was reported related to argininosuccinate synthase 1 and spermidine/spermine N1-acetyltransferase-mediated amino acid metabolism [36]. This evidence concerns the gene ASS1 and urinary bladder carcinoma.